News
Cross-species BBB-penetrant IV-delivered AAV gene therapy provides broad and robust CNS tau lowering in tauopathy mouse models and non-human primate (#559). Hechen Bao, Ph.D., Scientist II, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback